Evidence map›Paper›PMID 19692704›Full record

ArticleBlood2009

Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP.

Hervé Falet, Michael P Marchetti, Karin M Hoffmeister, Michel J Massaad, Raif S Geha, John H Hartwig

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. BAR proteins in cancer and blood disorders.International journal of biochemistry and molecular biology · 2012
    Article
  6. Article
  7. Novel clearance mechanisms of platelets.Current opinion in hematology · 2010
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hervé FaletDivision of Translational Medicine, Brigham and Women's Hospital, One Blackfan Cir, Karp 6, Boston, MA02115, USA. hfalet@rics.bwh.harvard.edu
Michael P Marchetti
Karin M Hoffmeister
Michel J Massaad
Raif S Geha
John H Hartwig
Harvard University · USBrigham and Women's Hospital · USBoston Children's Hospital · US

Funding

PREVENTION OF COLD INDUCED PLATELET STORAGE LESIONP01HL056949 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI WAGNER, DENISA D · 1996 to 2010
$26.2M
WIP in TCR signaling and actin reorganizationP01HL059561 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI GEHA, RAIF SALIM · 1997 to 2012
$21.8M
Carbohydrate-Mediated Platelet ClearanceR01HL089224 · NHLBI · VERSITI WISCONSIN, INC. · PI Karin Maria Hoffmeister · 2007 to 2026
$9.3M
TRANSGENIC MODELS OF T CELL RECEPTOR IMMUNODEFICIENCIESP01AI035714 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TERHORST, CORNELIS P · 1994 to 2007
$9.3M
REGULATION OF PLATELET SHAPE CHANGESR01HL056252 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HARTWIG, JOHN H · 1996 to 2008
$3.3M
NHLBI NIH HHS HL-056252NHLBI NIH HHS HL-056949NHLBI NIH HHS HL-059561NHLBI NIH HHS P01 HL056949NHLBI NIH HHS P01 HL059561NHLBI NIH HHS R01 HL056252NHLBI NIH HHS R01 HL089224NIAID NIH HHS AI-035714NIAID NIH HHS P01 AI035714
6 · The paper itself

Abstract

The role of the Wiskott-Aldrich syndrome protein (WASp) in platelet function is unclear because platelets that lack WASp function normally. WASp constitutively associates with WASp-interacting protein (WIP) in resting and activated platelets. The role of WIP in platelet function was investigated using mice that lack WIP or WASp. WIP knockout (KO) platelets lack WASp and thus are double deficient. WIP KO mice have a thrombocytopenia, similar to WASp KO mice, resulting in part from enhanced platelet clearance. Most WIP KO, but not WASp KO, mice evolved platelet-associated immunoglobulins (Ig) of the IgA class, which normalize their platelet survival but diminish their glycoprotein VI (GPVI) responses. Protein tyrosine phosphorylation, including that of phospholipase C-gamma2, and calcium mobilization are impaired in IgA-presenting WIP KO platelets stimulated through GPVI, resulting in defects in alpha-granule secretion, integrin alphaIIbbeta3 activation, and actin assembly. The anti-GPVI antibody JAQ1 induces the irreversible loss of GPVI from circulating platelets in wild-type mice, but not in WIP KO mice that bear high levels of platelet-associated IgAs. Together, the data indicate that platelet-associated IgAs negatively modulate GPVI signaling and function in WIP KO mice.

Indexed as

AnimalsBlood PlateletsBlotting, WesternCarrier ProteinsCytoskeletal ProteinsElectrophoresis, Polyacrylamide GelEnzyme-Linked Immunosorbent AssayFlow CytometryImmunoglobulin AMiceMice, KnockoutPlatelet Membrane GlycoproteinsSignal TransductionThrombocytopeniaWiskott-Aldrich Syndrome ProteinCarrier ProteinsCytoskeletal ProteinsImmunoglobulin APlatelet Membrane Glycoproteinsplatelet membrane glycoprotein VIWaspip protein, mouseWiskott-Aldrich Syndrome Protein

Identifiers

PMID19692704
PMCPMC2780308
OpenAlexW1981802664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.